Outlook Therapeutics (OTLK)
NASDAQ:OTLK
Holding OTLK?
Track your performance easily

Outlook Therapeutics (OTLK) Financial Statements

1,170 Followers

Outlook Therapeutics Financial Overview

Outlook Therapeutics's market cap is currently ―. The company's EPS TTM is $-10.751; its P/E ratio is -0.54; Outlook Therapeutics is scheduled to report earnings on December 19, 2024, and the estimated EPS forecast is $-0.81. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ 44.41M$ -68.59M$ -10.32M$ -13.30M$ -21.07M
EBITDA$ 44.44M$ -68.59M$ -10.29M$ -13.29M$ -21.06M
Net Income Common Stockholders$ 44.41M$ -114.29M$ -11.18M$ -12.99M$ -20.68M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 32.02M$ 47.23M$ 10.36M$ 23.39M$ 33.71M
Total Assets$ 47.09M$ 59.03M$ 21.68M$ 32.30M$ 44.45M
Total Debt$ 32.72M$ 44.74M$ 36.55M$ 35.56M$ 34.74M
Net Debt$ 699.81K$ -2.48M$ 26.19M$ 12.16M$ 1.03M
Total Liabilities$ 130.77M$ 193.26M$ 46.03M$ 46.74M$ 49.93M
Stockholders Equity$ -83.67M$ -134.24M$ -24.34M$ -14.44M$ -5.48M
Cash Flow-
Free Cash Flow$ -19.51M-$ -13.03M$ -12.74M$ -13.22M
Operating Cash Flow$ -19.51M$ -19.27M$ -13.03M$ -12.74M$ -13.22M
Investing Cash Flow-----
Financing Cash Flow$ 4.31M$ 56.14M$ -3.18K$ 2.42M$ 3.30M
Currency in USD

Outlook Therapeutics Earnings and Revenue History

Outlook Therapeutics Debt to Assets

Outlook Therapeutics Cash Flow

Outlook Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis